Quarterly report · Q1
4323.TEDINET S100RO43
Period2023-04-01 → 2023-06-30
Filed2023-08-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.6bn | 2023-04-01 → 2023-06-30 | Cons. | Net sales |
| Revenue | ¥23.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥5.1bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Operating income | ¥122m | 2023-04-01 → 2023-06-30 | Cons. | Operating income |
| Operating income | ¥261m | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Ordinary income | ¥134m | 2023-04-01 → 2023-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.5bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥290m | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥134m | 2023-04-01 → 2023-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥290m | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥62m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥224m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥63m | 2023-04-01 → 2023-06-30 | Cons. | Profit loss |
| Net income | ¥231m | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Total assets | ¥18.3bn | at 2023-06-30 | Cons. | Assets |
| Total assets | ¥17.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥16.4bn | at 2022-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.8bn | at 2023-06-30 | Cons. | Liabilities |
| Total liabilities | ¥6.6bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.5bn | at 2023-06-30 | Cons. | Net assets |
| Net assets / equity | ¥10.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.2bn | at 2022-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥9.0bn | at 2023-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥7.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥8.6bn | at 2023-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥8.3bn | at 2022-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.3bn | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.1bn | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥138m | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥542m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥64m | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥405m | 2023-04-01 → 2023-06-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥281m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥266m | 2022-04-01 → 2022-06-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥5.05 | 2023-04-01 → 2023-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥144.5 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.26 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 57.2% | at 2023-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 61.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.0% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 36
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-06-30 | −¥47m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-06-30 | −¥47m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-06-30 | −¥628m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥825m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥807m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥19m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥104m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥415m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥415m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥16m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue | 2023-04-01 → 2023-06-30 | ¥961m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue external | 2023-04-01 → 2023-06-30 | ¥960m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥407,000 |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | segment profit | 2023-04-01 → 2023-06-30 | ¥147m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-06-30 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-06-30 | ¥5.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-06-30 | ¥47m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-06-30 | ¥750m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥26m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥26m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | −¥513m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥688m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥682m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥6m |
| jpcrp040300-q1r_E05236-000Global Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥119m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥319m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥319m |
| jpcrp040300-q1r_E05236-000Medical Big Data Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥11m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥865m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥865m |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥67,000 |
| jpcrp040300-q1r_E05236-000Package Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥132m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥5.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥26m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥774m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 470
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in investment activities | Prior1YTDDuration | -63615000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | -137577000 | JPY |
| Net increase decrease in short term loans payable fin cf | Prior1YTDDuration | -9047000 | JPY |
| Net increase decrease in short term loans payable fin cf | CurrentYTDDuration | － | JPY |
| Repayments of lease obligations fin cf | Prior1YTDDuration | -6467000 | JPY |
| Repayments of lease obligations fin cf | CurrentYTDDuration | -5531000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -195000 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -157000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -248274000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -397228000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1YTDDuration | -1680000 | JPY |
| Dividends paid to non controlling interests fin cf | CurrentYTDDuration | -1752000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -265665000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -404669000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 37925000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 3287000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | 1808591000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 1780171000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 6463823000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 6793050000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 8272414000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 8573221000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E05236-000DXAndSIBusinessMember | 3253221000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E05236-000PackageBusinessReportableSegmentMember | 864897000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 319470000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q1r_E05236-000GlobalBusinessReportableSegmentMember | 681687000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 5119276000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 5119276000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E05236-000DXAndSIBusinessMember | 19620000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E05236-000PackageBusinessReportableSegmentMember | 67000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E05236-000MedicalBigDataBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q1r_E05236-000GlobalBusinessReportableSegmentMember | 6173000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 25860000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -25860000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E05236-000DXAndSIBusinessMember | 3272842000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E05236-000PackageBusinessReportableSegmentMember | 864965000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 319470000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q1r_E05236-000GlobalBusinessReportableSegmentMember | 687860000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 5145137000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -25860000 | JPY |
| Net sales | Prior1YTDDuration | 5119276000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E05236-000DXAndSIBusinessMember | 512139000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E05236-000PackageBusinessReportableSegmentMember | 132186000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E05236-000MedicalBigDataBusinessReportableSegmentMember | 10519000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q1r_E05236-000GlobalBusinessReportableSegmentMember | 119125000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 773971000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | -512590000 | JPY |
| Operating income | Prior1YTDDuration | 261380000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |